Literature DB >> 29597096

A sustainable solution for the activities of the European network for surveillance of congenital anomalies: EUROCAT as part of the EU Platform on Rare Diseases Registration.

Agnieszka Kinsner-Ovaskainen1, Monica Lanzoni2, Ester Garne3, Maria Loane4, Joan Morris5, Amanda Neville6, Ciarán Nicholl2, Judith Rankin7, Anke Rissmann8, David Tucker9, Simona Martin2.   

Abstract

The European Commission through its Directorates-General Joint Research Centre (DG JRC) and Health and Food Safety (DG SANTE) is developing the European Platform on Rare Diseases Registration (EU RD Platform) with the objective to set European-level standards for data collection and data sharing. In the field of rare diseases the EU RD Platform will be a source of information on available rare disease patient data with large transnational European coverage. One main function of the EU RD Platform is to enable interoperability for the >600 existing RD registries in Europe. The second function is to offer a sustainable solution for two large European surveillance networks: European Surveillance of Congenital Anomalies (EUROCAT) and Surveillance of Cerebral Palsy in Europe (SCPE). EUROCAT is European network of population-based registries for the epidemiological surveillance of congenital anomalies. It covers about one third of the European birth population. The Central Database contains about 800,000 cases with congenital anomalies among livebirths, stillbirths and terminations of pregnancy, reported using the same standardised classification and coding. These high quality data enables epidemiological surveillance of congenital anomalies, which includes estimating prevalence, prenatal diagnosis and perinatal mortality rates and the detection of teratogenic exposures among others. The network also develops recommendations for primary prevention in the Rare Diseases National Plans for medicinal drugs, food/nutrition, lifestyle, health services, and environmental pollution. The network has received the European Commission's support since its inception. In order to offer a sustainable solution for the continuation of EUROCAT activities, it was agreed that EUROCAT would become part of the EU RD Platform. In 2015, the European level-coordination activities and the Central Database were transferred to the DG JRC, where the JRC-EUROCAT Central Registry is now located. This paper describes the functioning of EUROCAT in the new setting, and gives an overview of the activities and the organisation of the JRC-EUROCAT Central Registry.
Copyright © 2018 The Authors. Published by Elsevier Masson SAS.. All rights reserved.

Entities:  

Keywords:  Congenital anomalies; EU RD Platform; EUROCAT; JRC-EUROCAT Central Registry; Surveillance

Mesh:

Year:  2018        PMID: 29597096     DOI: 10.1016/j.ejmg.2018.03.008

Source DB:  PubMed          Journal:  Eur J Med Genet        ISSN: 1769-7212            Impact factor:   2.708


  13 in total

1.  Gastrostomy and congenital anomalies: a European population-based study.

Authors:  Ester Garne; Joachim Tan; Maria Loane; Silvia Baldacci; Elisa Ballardini; Joanne Brigden; Clara Cavero-Carbonell; Laura García-Villodre; Mika Gissler; Joanne Given; Anna Heino; Sue Jordan; Elizabeth Limb; Amanda Julie Neville; Anke Rissmann; Michele Santoro; Leuan Scanlon; Stine Kjaer Urhoj; Diana G Wellesley; Joan Morris
Journal:  BMJ Paediatr Open       Date:  2022-06

2.  Linking a European cohort of children born with congenital anomalies to vital statistics and mortality records: A EUROlinkCAT study.

Authors:  M Loane; J E Given; J Tan; A Reid; D Akhmedzhanova; G Astolfi; I Barišić; N Bertille; L B Bonet; C C Carbonell; O Mokoroa Carollo; A Coi; J Densem; E Draper; E Garne; M Gatt; S V Glinianaia; A Heino; E Den Hond; S Jordan; B Khoshnood; S Kiuru-Kuhlefelt; K Klungsøyr; N Lelong; L R Lutke; A J Neville; L Ostapchuk; A Puccini; A Rissmann; M Santoro; I Scanlon; G Thys; D Tucker; S K Urhoj; H E K de Walle; D Wellesley; O Zurriaga; J K Morris
Journal:  PLoS One       Date:  2021-08-27       Impact factor: 3.240

3.  The venous system of E14.5 mouse embryos-reference data and examples for diagnosing malformations in embryos with gene deletions.

Authors:  Stefan H Geyer; Barbara Maurer-Gesek; Lukas F Reissig; Julia Rose; Fabrice Prin; Robert Wilson; Antonella Galli; Catherine Tudor; Jacqueline K White; Timothy J Mohun; Wolfgang J Weninger
Journal:  J Anat       Date:  2021-08-25       Impact factor: 2.921

4.  Maternal risk factors for the VACTERL association: A EUROCAT case-control study.

Authors:  Romy van de Putte; Iris A L M van Rooij; Cynthia P Haanappel; Carlo L M Marcelis; Han G Brunner; Marie-Claude Addor; Clara Cavero-Carbonell; Carlos M Dias; Elizabeth S Draper; Larraitz Etxebarriarteun; Miriam Gatt; Babak Khoshnood; Agnieszka Kinsner-Ovaskainen; Kari Klungsoyr; Jenny J Kurinczuk; Anna Latos-Bielenska; Karen Luyt; Mary T O'Mahony; Nicola Miller; Carmel Mullaney; Vera Nelen; Amanda J Neville; Isabelle Perthus; Anna Pierini; Hanitra Randrianaivo; Judith Rankin; Anke Rissmann; Florence Rouget; Bruno Schaub; David Tucker; Diana Wellesley; Awi Wiesel; Natalya Zymak-Zakutnia; Maria Loane; Ingeborg Barisic; Hermien E K de Walle; Jorieke E H Bergman; Nel Roeleveld
Journal:  Birth Defects Res       Date:  2020-04-22       Impact factor: 2.344

5.  Developing a Transnational Health Record Framework with Level-Specific Interoperability Guidelines Based on a Related Literature Review.

Authors:  Ah Ra Lee; Il Kon Kim; Eunjoo Lee
Journal:  Healthcare (Basel)       Date:  2021-01-13

6.  The Quality Evaluation of Rare Disease Registries-An Assessment of the Essential Features of a Disease Registry.

Authors:  Salma Rashid Ali; Jillian Bryce; Yllka Kodra; Domenica Taruscio; Luca Persani; Syed Faisal Ahmed
Journal:  Int J Environ Res Public Health       Date:  2021-11-15       Impact factor: 3.390

7.  Prevention of Neural Tube Defects in Europe: A Public Health Failure.

Authors:  Joan K Morris; Marie-Claude Addor; Elisa Ballardini; Ingeborg Barisic; Laia Barrachina-Bonet; Paula Braz; Clara Cavero-Carbonell; Elly Den Hond; Ester Garne; Miriam Gatt; Martin Haeusler; Babak Khoshnood; Nathalie Lelong; Agnieszka Kinsner-Ovaskainen; Sonja Kiuru-Kuhlefelt; Kari Klungsoyr; Anna Latos-Bielenska; Elizabeth Limb; Mary T O'Mahony; Isabelle Perthus; Anna Pierini; Judith Rankin; Anke Rissmann; Florence Rouget; Gerardine Sayers; Antonin Sipek; Sarah Stevens; David Tucker; Christine Verellen-Dumoulin; Hermien E K de Walle; Diana Wellesley; Wladimir Wertelecki; Eva Bermejo-Sanchez
Journal:  Front Pediatr       Date:  2021-06-24       Impact factor: 3.418

8.  A Nationwide Registry-Based Study on Mortality Due to Rare Congenital Anomalies.

Authors:  Verónica Alonso-Ferreira; Germán Sánchez-Díaz; Ana Villaverde-Hueso; Manuel Posada de la Paz; Eva Bermejo-Sánchez
Journal:  Int J Environ Res Public Health       Date:  2018-08-10       Impact factor: 3.390

9.  Maternal risk associated with the VACTERL association: A case-control study.

Authors:  Romy van de Putte; Hermien E K de Walle; Kirsten J M van Hooijdonk; Ivo de Blaauw; Carlo L M Marcelis; Arno van Heijst; Jacques C Giltay; Kirsten Y Renkema; Paul M A Broens; Erwin Brosens; Cornelius E J Sloots; Jorieke E H Bergman; Nel Roeleveld; Iris A L M van Rooij
Journal:  Birth Defects Res       Date:  2020-07-22       Impact factor: 2.344

10.  EUROlinkCAT protocol for a European population-based data linkage study investigating the survival, morbidity and education of children with congenital anomalies.

Authors:  Joan K Morris; Ester Garne; Maria Loane; Ingeborg Barisic; James Densem; Anna Latos-Bieleńska; Amanda Neville; Anna Pierini; Judith Rankin; Anke Rissmann; Hermien de Walle; Joachim Tan; Joanne Emma Given; Hugh Claridge
Journal:  BMJ Open       Date:  2021-06-28       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.